Han-ping P. Zhu
Zhejiang Key Lab Of Vaccine
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
MicroRNA-mediated regulation of the immune response in Calu-3 cells infected with a SARS-CoV-2 E gene variant.
Journal: Frontiers in microbiology
Published: June 09, 2025
Development of a two-component recombinant vaccine for COVID-19.
Journal: Frontiers in immunology
Published: October 20, 2024
Comparative transcriptomic analyzes of human lung epithelial cells infected with wild-type SARS-CoV-2 and its variant with a 12-bp missing in the E gene.
Journal: Frontiers in microbiology
Published: October 25, 2022
Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils.
Journal: Emerging microbes & infections
Published: July 05, 2022
Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2.
Journal: Viruses
Published: August 21, 2021
A SARS-CoV-2 variant with the 12-bp deletion at E gene.
Journal: Emerging microbes & infections
Published: October 29, 2020
Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell.
Journal: Virologica Sinica
Published: April 01, 2020
Global Gene Expression Analysis of the Brainstem in EV71- and CVA16-Infected Gerbils.
Journal: Viruses
Published: November 07, 2019
Genotype and evolution of hantavirus in Tiantai of Zhejiang province, 2011-2018
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: October 29, 2019
An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.
Journal: Vaccine
Published: March 19, 2019
Capsule switching of Neisseria meningitidis sequence type 7 serogroup A to serogroup X.
Journal: The Journal of infection
Published: July 22, 2017
Last Updated: 09/26/2026